The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1200K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altan, N.
Right arrow Articles by Simon, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altan, N.
Right arrow Articles by Simon, S. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Breast Cancer
Hazardous Substances DB
*DOXORUBICIN
*MONENSIN
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/5/1583/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 10, May 18, 1998 1583-1598


Articles

Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy

Nihal Altan*, Yu Chen*, Melvin Schindler{ddagger}, and Sanford M. Simon*

From the * Laboratory of Cellular Biophysics, Rockefeller University, New York 10021; and the {ddagger} Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Multidrug resistance (MDR) is a significant problem in the treatment of cancer. Chemotherapeutic drugs distribute through the cyto- and nucleoplasm of drug-sensitive cells but are excluded from the nucleus in drug-resistant cells, concentrating in cytoplasmic organelles. Weak base chemotherapeutic drugs (e.g., anthracyclines and vinca alkaloids) should concentrate in acidic organelles. This report presents a quantification of the pH for identified compartments of the MCF-7 human breast tumor cell line and demonstrates that (a) the chemotherapeutic Adriamycin concentrates in acidified organelles of drug-resistant but not drug-sensitive cells; (b) the lysosomes and recycling endosomes are not acidified in drug-sensitive cells; (c) the cytosol of drug-sensitive cells is 0.4 pH units more acidic than the cytosol of resistant cells; and (d) disrupting the acidification of the organelles of resistant cells with monensin, bafilomycin A1, or concanamycin A is sufficient to change the Adriamycin distribution to that found in drug-sensitive cells, rendering the cell vulnerable once again to chemotherapy. These results suggest that acidification of organelles is causally related to drug resistance and is consistent with the hypothesis that sequestration of drugs in acidic organelles and subsequent extrusion from the cell through the secretory pathways contribute to chemotherapeutic resistance.

Key Words: multidrug resistance • pH • secretion • chemotherapy • breast cancer


Address correspondence to Sanford Simon, Laboratory of Cellular Biophysics, Box 304, Rockefeller University, 1230 York Ave., New York, NY 10021. Phone: 212-327-8130; Fax: 212-327-8022; E-mail: simon{at}rockvax.rockefeller.edu

N. Altan would like to thank the Merinoff Foundation, M. Schindler the Pardee Foundation (Midland, MI), and S.M. Simon the Keck Foundation, the Wolfensohn Foundation, the William and Helen Mazer Foundation, and the Irving A. Hansen Memorial Foundation for their financial support. Y. Chen was supported by National Institutes of Health grant MSTP GM-07739.

Abbreviations used: LAMP, lysosome-associated membrane protein; MDR, multidrug resistance; MRP, MDR-associated protein; Pgp, P-glycoprotein; PSS, protonation, sequestration, and secretion; SNARF, seminaphthorhodafluor; TGN, trans-Golgi network.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS